Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2) - Concepedia

Concepedia

Publication | Open Access

Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)

DOI Full Paper Access

131

Citations

5

References

2023

Year

Ohsang Kwon, Maryanne M. Senna, Rodney Sinclair, Taisuke Ito, Yves Dutronc, Chen‐Yen Lin, Guanglei Yu, Chiara Chiasserini, Jill Shwed McCollam, Wen-Shuo Wu,

American Journal of Clinical Dermatology

References

	Year	Citations

Page 1